The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond

SIMPLE SUMMARY: There is no doubt that immunotherapeutic approaches will change the current treatment landscape of multiple myeloma in the near future; in particular, a wave of BCMA-targeted therapies is currently entering clinical routine. Although the increasing availability of different therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Strassl, Irene, Schreder, Martin, Steiner, Normann, Rudzki, Jakob, Agis, Hermine, Künz, Tina, Müser, Nino, Willenbacher, Wolfgang, Petzer, Andreas, Neumeister, Peter, Krauth, Maria Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471156/
https://www.ncbi.nlm.nih.gov/pubmed/34572927
http://dx.doi.org/10.3390/cancers13184701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471156/
https://www.ncbi.nlm.nih.gov/pubmed/34572927
http://dx.doi.org/10.3390/cancers13184701

Ejemplares similares